These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

589 related items for PubMed ID: 10498889

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
    Zhang L, Yang N, Park JW, Katsaros D, Fracchioli S, Cao G, O'Brien-Jenkins A, Randall TC, Rubin SC, Coukos G.
    Cancer Res; 2003 Jun 15; 63(12):3403-12. PubMed ID: 12810677
    [Abstract] [Full Text] [Related]

  • 3. Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2.
    Vajkoczy P, Farhadi M, Gaumann A, Heidenreich R, Erber R, Wunder A, Tonn JC, Menger MD, Breier G.
    J Clin Invest; 2002 Mar 15; 109(6):777-85. PubMed ID: 11901186
    [Abstract] [Full Text] [Related]

  • 4. Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: possible in vivo regulation via induction of proteases.
    Etoh T, Inoue H, Tanaka S, Barnard GF, Kitano S, Mori M.
    Cancer Res; 2001 Mar 01; 61(5):2145-53. PubMed ID: 11280779
    [Abstract] [Full Text] [Related]

  • 5. Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis.
    Goede V, Schmidt T, Kimmina S, Kozian D, Augustin HG.
    Lab Invest; 1998 Nov 01; 78(11):1385-94. PubMed ID: 9840613
    [Abstract] [Full Text] [Related]

  • 6. Immunohistochemical study of VEGF, angiopoietin 2 and their receptors in the neovascularization following microinjection of C6 glioma cells into rat brain.
    Péoch M, Farion R, Hiou A, Le Bas JF, Pasquier B, Rémy C.
    Anticancer Res; 2002 Nov 01; 22(4):2147-51. PubMed ID: 12174896
    [Abstract] [Full Text] [Related]

  • 7. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.
    Holash J, Maisonpierre PC, Compton D, Boland P, Alexander CR, Zagzag D, Yancopoulos GD, Wiegand SJ.
    Science; 1999 Jun 18; 284(5422):1994-8. PubMed ID: 10373119
    [Abstract] [Full Text] [Related]

  • 8. The clinical implications of angiogenesis in the treatment of cancer.
    Aoun E, Taher A.
    J Med Liban; 2002 Jun 18; 50(1-2):32-8. PubMed ID: 12841311
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In situ expression of angiopoietins in astrocytomas identifies angiopoietin-2 as an early marker of tumor angiogenesis.
    Zagzag D, Hooper A, Friedlander DR, Chan W, Holash J, Wiegand SJ, Yancopoulos GD, Grumet M.
    Exp Neurol; 1999 Oct 18; 159(2):391-400. PubMed ID: 10506510
    [Abstract] [Full Text] [Related]

  • 12. In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor.
    Middeke M, Hoffmann S, Hassan I, Wunderlich A, Hofbauer LC, Zielke A.
    Exp Clin Endocrinol Diabetes; 2002 Nov 18; 110(8):386-92. PubMed ID: 12518248
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Lymphatic versus blood vascular endothelial growth factors and receptors in humans.
    Partanen TA, Paavonen K.
    Microsc Res Tech; 2001 Oct 15; 55(2):108-21. PubMed ID: 11596156
    [Abstract] [Full Text] [Related]

  • 15. Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis.
    Saaristo A, Karpanen T, Alitalo K.
    Oncogene; 2000 Dec 11; 19(53):6122-9. PubMed ID: 11156525
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
    Quentin T, Schlott T, Korabiowska M, Käthei N, Zöller G, Glaser F, Kunze E.
    Anticancer Res; 2004 Dec 11; 24(5A):2745-56. PubMed ID: 15517881
    [Abstract] [Full Text] [Related]

  • 18. NERF2, a member of the Ets family of transcription factors, is increased in response to hypoxia and angiopoietin-1: a potential mechanism for Tie2 regulation during hypoxia.
    Christensen RA, Fujikawa K, Madore R, Oettgen P, Varticovski L.
    J Cell Biochem; 2002 Dec 11; 85(3):505-15. PubMed ID: 11967990
    [Abstract] [Full Text] [Related]

  • 19. Vascular endothelial growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sites.
    Guo P, Xu L, Pan S, Brekken RA, Yang ST, Whitaker GB, Nagane M, Thorpe PE, Rosenbaum JS, Su Huang HJ, Cavenee WK, Cheng SY.
    Cancer Res; 2001 Dec 01; 61(23):8569-77. PubMed ID: 11731444
    [Abstract] [Full Text] [Related]

  • 20. Endothelial survival factors as targets for antineoplastic therapy.
    Reinmuth N, Stoeltzing O, Liu W, Ahmad SA, Jung YD, Fan F, Parikh A, Ellis LM.
    Cancer J; 2001 Dec 01; 7 Suppl 3():S109-19. PubMed ID: 11779081
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.